Use of Rivaroxaban and Apixaban, Two Non-Vitamin K Antagonist Oral Anticoagulants (NOACs), in Renally Impaired Patients - the limits of our knowledge
Crossref DOI link: https://doi.org/10.29328/journal.jccm.1001026
Published Online: 2018-10-11
Update policy: https://doi.org/10.29328/crossmark-policy
Moore, Kenneth T
Langas, Maria
License valid from 2018-10-11
Version of Record valid from 2013-11-25
Accepted Manuscript valid from 2016-04-18
